SSM Health’s plans to upend the drug market are still on target for a 2018 launch, CEO Laura Kaiser told Wisconsin Health News in an interview Tuesday.
To access this content, you must purchase a Premium membership, or log in if you are a member.
Support Our Advertisers
STAY INFORMED ON THE STATE’S MOST PRESSING HEALTHCARE ISSUES AND INITIATIVES.
Subscribe here for a FREE 14 day trial of our daily news roundup.